Orgenesis Inc. (NASDAQ:ORGS – Get Free Report) shares dropped 3.3% on Wednesday . The stock traded as low as $0.50 and last traded at $0.50. Approximately 34,800 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 218,907 shares. The stock had previously closed at $0.52.
Orgenesis Stock Down 3.3 %
The firm has a 50-day moving average price of $0.65 and a two-hundred day moving average price of $0.57. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 1.48. The company has a market capitalization of $17.24 million, a P/E ratio of -0.55 and a beta of 1.07.
Orgenesis Company Profile
Orgenesis Inc, a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network.
Featured Articles
- Five stocks we like better than Orgenesis
- Stock Market Sectors: What Are They and How Many Are There?
- High-Yield Texas Instruments Could Hit New Highs Soon
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Options Trading – Understanding Strike Price
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
